cancer (OR: 1.28, p < 0.001) and specifically for significant prostate cancer (OR: 1.46, p < 0.001) in uni-variate analyses. However, multi-variate analyses using age, PSA, prostate volume, DRE and transrectal ultrasonography outcome, and previous biopsy (yes/no) showed that PSAV was not ...
This story is about 73-year-old Johnny who had prostate cancer that had spread extensively to this bones. There is indication that the cancer has also spread to his lungs. Johnny was admitted into a private hospital for treatment. Unfortunately, nothing much came out of this “hospital adventu...
Multiparametric MRI of the prostate is now recommended as the initial diagnostic test for men presenting with suspected prostate cancer, with a negative MRI enabling safe avoidance of biopsy and a positive result enabling MRI-directed sampling of lesions. The diagnostic pathway consists of several step...
leading to a preference for the transperineal approach. The transition gained momentum in the 1950s, with increasing recognition of transrectal biopsy’s potential for enhanced precision in prostate cancer detection. The advent of ultrasound imaging, notably described...
Overdiagnosis and overtreatment of prostate cancer. Eur. Urol. 65, 1046–1055 (2014). PubMed PubMed Central Google Scholar Serefoglu, E. C. et al. How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? Can. Urol. Assoc. J. 7, E293–E298 (2013). ...
In the clinical world after MRI, mostly a biopsy procedure takes place in which an ultrasound image (US) gets merged with an MR image to generate a 3D image of the prostate gland. In recent years MRI-US merged strategy has upgraded the cancer biopsy but has certain limitations causing ...
Fig. 5: Comparative assessment of biological factors underpinning HP-13C-MRI-visibility of biopsy-proven PCa. a,bWhole-mount H&E, ADC, along with [1-13C]pyruvate and [1-13C]lactate SNR maps demonstrating the presence of large, cellular ISUP GG3 lesions with dominant ICC component that we...
Managing the impact of inter-method bias of prostate specific antigen assays on biopsy referral: the key to move towards precision health in prostate cancer management Simona Ferraro , Giacomo Biganzoli , Marco Bussetti , Silvana Castaldi , Elia Mario Biganzoli and Mario Plebani From the journa...
Multiparametric MRI of the prostate is now recommended as the initial diagnostic test for men presenting with suspected prostate cancer, with a negative MRI enabling safe avoidance of biopsy and a positive result enabling MRI-directed sampling of lesions. The diagnostic pathway consists of several step...
British Journal of Cancer (2011) 105, 481 – 485 & 2011 Cancer Research UK All rights reserved 0007 – 0920/11 www.bjcancer.com Ethnic differences in prostate cancer P Kheirandish*,1,2 and F Chinegwundoh1,2 1Department of Urology, St Bartholomew's hospital, Barts and The London NHS ...